1
|
Michael Robie E, Cole S, Suwal A, Coustasse A. Tele-ICU in the Unites States: Is a cost-effective model? INTERNATIONAL JOURNAL OF HEALTHCARE MANAGEMENT 2022. [DOI: 10.1080/20479700.2022.2040877] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- E. Michael Robie
- Healthcare Administration Program, Lewis College of Business, Marshall University, South Charleston, WV 25303 USA
| | - Stephanie Cole
- Healthcare Administration Program, Lewis College of Business, Marshall University, South Charleston, WV 25303 USA
| | - Archana Suwal
- Healthcare Administration Program, Lewis College of Business, Marshall University, South Charleston, WV 25303 USA
| | - Alberto Coustasse
- Healthcare Administration Program, Lewis College of Business, Marshall University, South Charleston, WV 25303 USA
| |
Collapse
|
2
|
UyaroĞlu OA, BaŞaran NÇ, ÖziŞik L, Dİzman GT, EroĞlu İ, Şahİn TK, TaŞ Z, İnkaya AÇ, TanriÖver MD, Metan G, GÜven GS, Ünal S. Thirty-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey: an observational, single-center study. Int J Qual Health Care 2021; 33:5940459. [PMID: 33104780 PMCID: PMC7665548 DOI: 10.1093/intqhc/mzaa144] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2020] [Revised: 10/01/2020] [Accepted: 10/22/2020] [Indexed: 02/07/2023] Open
Abstract
Background The 30-day readmission rate is an important indicator of patient safety and hospital’s quality performance. In this study, we aimed to find out the 30-day readmission rate of mild and moderate severity COVID-19 patients discharged from a tertiary care university hospital and to demonstrate the possible factors associated with readmission. Methods This is an observational, single-center study. Epidemiological and clinical data of patients who were hospitalized with a diagnosis of COVID-19 were retrieved from a research database where patient information was recorded prospectively. Readmission data was sought from the hospital information management system and National Health Record System to detect if the patients were readmitted to any hospital within 30 days of discharge. Adult patients (≥18 years-old) hospitalized in COVID-19 wards with a diagnosis of mild or moderate COVID-19 between March 20, 2020 (when the first case was admitted to our hospital), and April 26, 2020 were included. Results From March 26 to May 1, there were 154 mild or moderate severity (non-critical) COVID-19 patients discharged from COVID-19 wards, of which 11 (7.1%) were readmitted The median time of readmission was 8.1 days (IQR=5.2). Two patients (18.1%) were categorized to have mild disease and the remaining 9 (81.9%) as moderate disease. Two patients who were over 65 years of age and had metastatic cancers and hypertension developed sepsis and died in the hospital during the readmission episode. Malignancy (18.7% vs 2.1%, P = 0.04) and hypertension (45.5% vs 14%, P = 0.02) were more common in those who were readmitted. Conclusions This is one of the first studies to report on 30-day readmission rate of COVID-19 in the literature. More comprehensive studies are needed to reveal the causes and predictors of COVID-19 readmissions.
Collapse
Affiliation(s)
- Oğuz Abdullah UyaroĞlu
- Faculty of Medicine, Department of Internal Medicine, Section of General Internal Medicine, Hacettepe University, Sıhhiye, Ankara, 06430, Turkey
| | - Nursel Çalik BaŞaran
- Faculty of Medicine, Department of Internal Medicine, Section of General Internal Medicine, Hacettepe University, Sıhhiye, Ankara, 06430, Turkey
| | - Lale ÖziŞik
- Faculty of Medicine, Department of Internal Medicine, Section of General Internal Medicine, Hacettepe University, Sıhhiye, Ankara, 06430, Turkey
| | - Gülçİn Tellİ Dİzman
- Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Hacettepe University, Sıhhiye, Ankara, 06430, Turkey
| | - İmdat EroĞlu
- Faculty of Medicine, Department of Internal Medicine, Hacettepe University, Sıhhiye, Ankara, 06430, Turkey
| | - Taha Koray Şahİn
- Faculty of Medicine, Department of Internal Medicine, Hacettepe University, Sıhhiye, Ankara, 06430, Turkey
| | - Zahİt TaŞ
- Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Hacettepe University, Sıhhiye, Ankara, 06430, Turkey
| | - Ahmet Çağkan İnkaya
- Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Hacettepe University, Sıhhiye, Ankara, 06430, Turkey
| | - Mıne Durusu TanriÖver
- Faculty of Medicine, Department of Internal Medicine, Section of General Internal Medicine, Hacettepe University, Sıhhiye, Ankara, 06430, Turkey
| | - Gökhan Metan
- Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Hacettepe University, Sıhhiye, Ankara, 06430, Turkey
| | - Gülay Saİn GÜven
- Faculty of Medicine, Department of Internal Medicine, Section of General Internal Medicine, Hacettepe University, Sıhhiye, Ankara, 06430, Turkey
| | - Serhat Ünal
- Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Hacettepe University, Sıhhiye, Ankara, 06430, Turkey
| |
Collapse
|